Yıl: 2019 Cilt: 27 Sayı: 3 Sayfa Aralığı: 186 - 195 Metin Dili: İngilizce DOI: 10.5336/mdethic.2019-66097 İndeks Tarihi: 03-06-2020

Is Medical Schools, Curricula Content of Pharmacovigilance and Rational Pharmacotherapy- Related Subjects Sufficient for Future Physicians?

Öz:
Underreporting of adverse drug reactions (ADRs) is a global problem and the main reasons fornot reporting ADRs are either failure to recognize an ADR or failure to report the recognized ADR, whichcan be prevented by efficient education and training. Thus, the content on pharmacovigilance and relatedsubjects in the curricula of the medical schools was evaluated. The web pages of the 63 Turkish medicalschools that provided online curricula were evaluated for the following subjects: pharmacovigilance, toxicology,rational pharmacotherapy, drug use in special populations, good prescription writing principles, andclinical pharmacology stage. The number of hours dedicated to these subjects and the year of the course duringwhich these subjects were taught were recorded. Of the 63 medical schools, 41 (65.1%) provide pharmacovigilancecourse and 33 (52.4%) rational pharmacotherapy course for 0.5-2 hours, mostly during the 3rdyear of education. Thirty of the medical schools (47.6%) had clinical pharmacology and rational pharmacotherapystage covering personal-drug selection, and clinical pharmacology of organ-systems was mostly afive-day course during the 4th or 5th years of education. The time allocated for pharmacovigilance and relatedsubjects in the curricula of medical schools is not sufficient for the students to acquire satisfactoryknowledge on ADR and to influence their attitudes as physicians in the future. In order to improve this,more time and effort must be allocated by medical schools to pharmacovigilance and rational pharmacotherapyeducation, particularly during the later years of medical education.
Anahtar Kelime:

Tıp Fakülteleri Ders Programlarında Farmakovijilans ve Akılcı Farmakoterapi ile İlişkili Konuların Kapsanması Gelecekteki Doktorlar Açısından Yeterli Midir?

Öz:
Advers ilaç reaksiyonlarının (AİR) yeterince bildirilmemesi küresel bir sorundur ve bildirmemenin temel nedenleri AİR'lerin fark edilmemesi veya fark edilse bile bildirilmemesidir. Bu durumun üstesinden ancak yeterli eğitim ile gelinebilir. Tıp fakülteleri ders programlarında farmakovijilans ve ilgili konuların varlığı bu nedenle değerlendirildi. Türkiye’de bulunan tıp fakültelerinin 63'ü web sayfalarında ayrıntılı ders programlarını paylaşmaktadır. Bu ders programları şu konuların varlığı açısından incelenmiştir: farmakovijilans, toksikoloji, akılcı farmakoterapi, özel popülasyonlarda ilaç kullanımı, iyi reçete yazma kuralları, klinik farmakoloji stajı. Bu konuların hangi sınıfta öğretildiği ve ne kadar süre ayrıldığı kaydedilmiştir. İncelenen 63 tıp fakültesinden 41’i (%65,1) farmakovijilans dersini ve 33’ü (%52,4) akılcı farmakoterapi dersini 0,5-2 saat süre ile ve genellikle 3. sınıfta sunmaktadır. Otuz (%47,6) okul genellikle 4 veya 5. sınıfta beş iş günü süren klinik farmakoloji ve akılcı farmakoterapi stajı vermektedir ve bu staj sırasında kişisel ilaç seçimi, organsisteme özgü ilaçların klinik farmakolojisi gibi konular kapsanmaktadır. Tıp fakülteleri eğitim programında farmakovijilans ve ilgili konulara ayrılan süre tıp öğrencisinin AİR ile ilgili tatmin edici düzeyde bilgi sahibi olması ve gelecekteki doktorlar olarak gerekli davranışı edinebilmeleri için yeterli değildir. Bu durumu düzeltmek için tıp eğitiminde farmakovijilans ve akılcı farmakoterapiye daha fazla zaman ve emek, özellikle tıp eğitiminin son yıllarında verilmelidir.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Inman WH. Attitudes to adverse drug reaction reporting. Br J Clin Pharmacol. 1996;41(5): 434-5. [PubMed]
  • 2. Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385-96. [Crossref] [PubMed]
  • 3. Aagaard L, Strandell J, Melskens L, Petersen PS, Holme Hansen E. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™. Drug Saf. 2012;35(12):1171-82. [Crossref] [PubMed]
  • 4. Dal Pan GJ. Ongoing challenges in pharmacovigilance. Drug Saf. 2014;37(1):1-8. [Crossref] [PubMed]
  • 5. Hohl CM, Small SS, Peddie D, Badke K, Bailey C, Balka E. Why clinicians don’t report adverse drug events: qualitative study. JMIR Public Health Surveill. 2018;4(1):e21. [Crossref] [PubMed] [PMC]
  • 6. Güner MD, Ekmekci PE. Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates. J Drug Assess. 2019;8(1):13-20. [Crossref] [PubMed] [PMC]
  • 7. Kaeding M, Schmälter J, Klika C. Pharmacovigilance in the European Union. Practical Implementation Across Member States. New York: Springer; 2017. p.124. [Crossref]
  • 8. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ. 2004;329(7456):15-9. [Crossref] [PubMed] [PMC]
  • 9. Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM; HARM Study Group. Frequency of and risk factors for preventable medication related hospital admissions in The Netherlands. Arch Intern Med. 2008;168(17):1890-6. [PubMed]
  • 10. Angamo MT, Chalmers L, Curtain CM, Bereznicki LR. Adverse drug reaction related hospitalisations in developed and developing countries: a review of prevalence and contributing factors. Drug Saf. 2016;39(9):847-57. [Crossref] [PubMed]
  • 11. Ozcan G, Aykac E, Kasap Y, Nemutlu NT, Sen E, Aydinkarahaliloglu ND. Adverse drug reaction reporting pattern in Turkey: analysis of the national database in the context of the first pharmacovigilance legislation. Drugs Real World Outcomes. 2016;3(1):33-43. [Crossref] [PubMed] [PMC]
  • 12. Gonzalez-Gonzalez C, Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Strategies to improve adverse drug reaction reporting: a critical and systematic review. Drug Saf. 2013;36(5):317-28. [Crossref] [PubMed]
  • 13. Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32(1):19-31. [Crossref] [PubMed]
  • 14. de Vries TPGM, Henning RH, Hogerzeil HV, Fresle DA. Guide to good prescribing-a practical manual. Geneva: World Health Organization Action Programme on Essential Drugs; 1994. p.123.
  • 15. Hartman J, Härmark L, van Puijenbroek E. A global view of undergraduate education in pharmacovigilance. Eur J Clin Pharmacol. 2017;73(7):891-9. [Crossref] [PubMed]
  • 16. Reumerman M, Tichelaar J, Piersma B, Richir MC, van Agtmael MA. Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature. Eur J Clin Pharmacol. 2018;74(10):1235-48. [Crossref] [PubMed] [PMC]
  • 17. Pagotto C, Varallo F, Mastroianni P. Impact of educational interventions on adverse drug events reporting. Int J Technol Assess Health Care. 2013;29(4):410-7. [Crossref] [PubMed]
  • 18. Pedrós C, Vallano A, Cereza G, MendozaAran G, Agustí A, Aguilera C, et al. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain. Drug Saf. 2009;32(1):77-83. [Crossref] [PubMed]
  • 19. Figueiras A, Herdeiro MT, Polónia J, GestalOtero JJ. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA. 2006;296(9):1086-93. [Crossref] [PubMed]
  • 20. Herdeiro MT, Polónia J, Gestal-Otero JJ, Figueiras A. Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in Portugal. Drug Saf. 2008;31(4):335-44. [Crossref] [PubMed]
  • 21. Herdeiro MT, Ribeiro-Vaz I, Ferreira M, Polónia J, Falcão A, Figueiras A. Workshop-and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal. Drug Saf. 2012;35(8):655-65. [Crossref] [PubMed]
  • 22. Gerritsen R, Faddegon H, Dijkers F, van Grootheest K, van Puijenbroek E. Effectiveness of pharmacovigilance training of general practitioners: a retrospective cohort study in the Netherlands comparing two methods. Drug Saf. 2011;34(9):755-62. [Crossref] [PubMed]
  • 23. Elkalmi RM, Hassali MA, Ibrahim MI, Widodo RT, Efan QM, Hadi MA. Pharmacy student’s knowledge and perceptions about pharmacovigilance in Malaysian public universities. Am J Pharm Educ. 2011;75(5):96. [Crossref] [PubMed] [PMC]
  • 24. Maxwell SR. How should teaching of undergraduates in clinical pharmacology and therapeutics be delivered and assessed? Br J Clin Pharmacol. 2012;73(6):893-9. [Crossref] [PubMed] [PMC]
  • 25. Arici MA, Gelal A, Demiral Y, Tuncok Y. Short and long-term impact of pharmacovigilance training on the pharmacovigilance knowledge of medical students. Indian J Pharmacol. 2015;47(4):436-9. [Crossref] [PubMed] [PMC]
  • 26. Umair Khan M, Ahmad A, Ejaz A, Ata Rizvi S, Sardar A, Hussain K, et al. Comparison of the knowledge, attitudes and perception of barriers regarding adverse drug reaction reporting between pharmacy and medical students in Pakistan. J Educ Eval Health Prof. 2015;12:28. [Crossref] [PubMed] [PMC]
  • 27. Abubakar AR, Haque M. Pharmacovigilance practice: the current challenges and the gaps in the medical students’ curriculum. J App Pharm Sci. 2016;6(5):210-5. [Crossref]
  • 28. Othman GQ, Ibrahim MIM, Alshakka M, Ansari M, Al-Qadasi F, Halboup AM. Knowledge and perception about pharmacovigilance among pharmacy students of universities in Sana’s Yemen. J Clin Diagn Res. 2017;11(6):FC09- 13. [Crossref] [PubMed] [PMC]
  • 29. Schutte T, Tichelaar J, Reumerman MO, van Eekeren R, Rissmann R, Kramers C, et al; Education Committee/Working Group Research in Education of the Dutch Society of Clinical Pharmacology and Biopharmacy (NVKF&B), Utrecht, The Netherlands. Pharmacovigilance skills, knowledge and attitudes in our future doctors-a nationwide study in the Netherlands. Basic Clin Pharmacol Toxicol. 2017;120(5):475-81. [Crossref] [PubMed]
  • 30. Durrieu G, Hurault C, Damase-Michel C, Montastruc JL. Perception of risk of adverse drug reactions: a 3-year follow-up of a cohort of medical students. Fundam Clin Pharmacol. 2010;24(4):423-7. [Crossref] [PubMed]
  • 31. Tripathi RK, Jalgaonkar SV, Sarkate PV, Rege NN. Implementation of a module to promote competency in adverse drug reaction reporting in undergraduate medical students. Indian J Pharmacol. 2016;48(Suppl 1):S69-73. [Crossref] [PubMed] [PMC]
  • 32. King M, Khan S. The development and piloting of “ATTEND DR,” a clinical teaching tool to identify and prioritize potential causes of adverse drug reactions. Curr Pharm Teach Learn. 2017;9(1):66-71. [Crossref] [PubMed]
  • 33. Patel PB, Patel TK, Anturlikar S, Khatun S, Bhabhor P, Saurabh MK. Adverse drug reactions reporting by undergraduate medical students in a tertiary care teaching hospital of India: content and quality analysis in comparison to physician reporting. Perspect Clin Res. 2017;8(3):137-44. [PubMed]
  • 34. Bracchi RC, Houghton J, Woods FJ, Thomas S, Smail SA, Routledge PA. A distance-learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via the UK yellow card scheme. Br J Clin Pharmacol. 2005;60(2):221-3. [Crossref] [PubMed] [PMC]
  • 35. Johansson-Pajala RM, Martin L, Fastbom J, Jorsäter Blomgren K. Nurses’ self-reported medication competence in relation to their pharmacovigilant activities in clinical practice. J Eval Clin Pract. 2015;21(1):145-52. [Crossref] [PubMed]
  • 36. Ribeiro-Vaz I, Santos CC, Cruz-Correia R. Promoting adverse drug reaction reporting: comparison of different approaches. Rev Saude Publica. 2016;50:14. [Crossref] [PubMed] [PMC]
  • 37. Ribeiro-Vaz I, Herdeiro MT, Polónia J, Figueiras A. Strategies to increase the sensitivity of pharmacovigilance in Portugal. Rev Saude Publica. 2011;45(1):129-35. [Crossref] [PubMed]
  • 38. van Eekeren R, Rolfes L, Koster AS, Magro L, Parthasarathi G, Al Ramimmy H, et al. What future healthcare professionals need to know about pharmacovigilance: introduction of the WHO PV core curriculum for university teaching with focus on clinical aspects. Drug Saf. 2018;41(11):1003-11. [Crossref] [PubMed] [PMC]
  • 39. Ross S, Maxwell S. Prescribing and the core curriculum for tomorrow’s doctors: BPS curriculum in clinical pharmacology and prescribing for medical students. Br J Clin Pharmacol. 2012;74(4):644-61. [Crossref] [PubMed] [PMC]
  • 40. Brinkman DJ, Tichelaar J, Okorie M, Bissell L, Christiaens T, Likic R, et al; Education Working Group of the European Association for Clinical Pharmacology and Therapeutics (EACPT). Pharmacology and Therapeutics Education in the European Union Needs Harmonization and Modernization: a cross-sectional survey among 185 medical schools in 27 countries. Clin Pharmacol Ther. 2017; 102(5):815-22. [Crossref] [PubMed] [PMC]
  • 41. Brinkman DJ, Tichelaar J, Schutte T, Benemei S, Böttiger Y, Chamontin B, et al; Working Group Research on CPT Education of the European Association for Clinical Pharmacology and Therapeutics (EACPT). Essential competencies in prescribing: a first European crosssectional study among 895 final-year medical students. Clin Pharmacol Ther. 2017;101(2): 281-9. [Crossref] [PubMed] [PMC]
  • 42. Brinkman DJ, Tichelaar J, Mokkink LB, Christiaens T, Likic R, Maciulaitis R, et al; Education Working Group of the European Association for Clinical Pharmacology and Therapeutics (EACPT) and its affiliated Network of Teachers in Pharmacotherapy (NOTIP). Key learning outcomes for clinical pharmacology and therapeutics education in Europe: a modified Delphi study. Clin Pharmacol Ther. 2018;104(2):317-25. [Crossref] [PubMed] [PMC]
  • 43. Beckmann J, Hagemann U, Bahri P, Bate A, Boyd IW, Dal Pan GJ, et al. Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculum. Drug Saf. 2014;37(10):743-59. [Crossref] [PubMed]
APA GÜNER M, EKMEKÇİ P (2019). Is Medical Schools, Curricula Content of Pharmacovigilance and Rational Pharmacotherapy- Related Subjects Sufficient for Future Physicians?. , 186 - 195. 10.5336/mdethic.2019-66097
Chicago GÜNER Müberra Devrim,EKMEKÇİ Perihan Elif Is Medical Schools, Curricula Content of Pharmacovigilance and Rational Pharmacotherapy- Related Subjects Sufficient for Future Physicians?. (2019): 186 - 195. 10.5336/mdethic.2019-66097
MLA GÜNER Müberra Devrim,EKMEKÇİ Perihan Elif Is Medical Schools, Curricula Content of Pharmacovigilance and Rational Pharmacotherapy- Related Subjects Sufficient for Future Physicians?. , 2019, ss.186 - 195. 10.5336/mdethic.2019-66097
AMA GÜNER M,EKMEKÇİ P Is Medical Schools, Curricula Content of Pharmacovigilance and Rational Pharmacotherapy- Related Subjects Sufficient for Future Physicians?. . 2019; 186 - 195. 10.5336/mdethic.2019-66097
Vancouver GÜNER M,EKMEKÇİ P Is Medical Schools, Curricula Content of Pharmacovigilance and Rational Pharmacotherapy- Related Subjects Sufficient for Future Physicians?. . 2019; 186 - 195. 10.5336/mdethic.2019-66097
IEEE GÜNER M,EKMEKÇİ P "Is Medical Schools, Curricula Content of Pharmacovigilance and Rational Pharmacotherapy- Related Subjects Sufficient for Future Physicians?." , ss.186 - 195, 2019. 10.5336/mdethic.2019-66097
ISNAD GÜNER, Müberra Devrim - EKMEKÇİ, Perihan Elif. "Is Medical Schools, Curricula Content of Pharmacovigilance and Rational Pharmacotherapy- Related Subjects Sufficient for Future Physicians?". (2019), 186-195. https://doi.org/10.5336/mdethic.2019-66097
APA GÜNER M, EKMEKÇİ P (2019). Is Medical Schools, Curricula Content of Pharmacovigilance and Rational Pharmacotherapy- Related Subjects Sufficient for Future Physicians?. Türkiye Klinikleri Tıp Etiği-Hukuku Tarihi Dergisi, 27(3), 186 - 195. 10.5336/mdethic.2019-66097
Chicago GÜNER Müberra Devrim,EKMEKÇİ Perihan Elif Is Medical Schools, Curricula Content of Pharmacovigilance and Rational Pharmacotherapy- Related Subjects Sufficient for Future Physicians?. Türkiye Klinikleri Tıp Etiği-Hukuku Tarihi Dergisi 27, no.3 (2019): 186 - 195. 10.5336/mdethic.2019-66097
MLA GÜNER Müberra Devrim,EKMEKÇİ Perihan Elif Is Medical Schools, Curricula Content of Pharmacovigilance and Rational Pharmacotherapy- Related Subjects Sufficient for Future Physicians?. Türkiye Klinikleri Tıp Etiği-Hukuku Tarihi Dergisi, vol.27, no.3, 2019, ss.186 - 195. 10.5336/mdethic.2019-66097
AMA GÜNER M,EKMEKÇİ P Is Medical Schools, Curricula Content of Pharmacovigilance and Rational Pharmacotherapy- Related Subjects Sufficient for Future Physicians?. Türkiye Klinikleri Tıp Etiği-Hukuku Tarihi Dergisi. 2019; 27(3): 186 - 195. 10.5336/mdethic.2019-66097
Vancouver GÜNER M,EKMEKÇİ P Is Medical Schools, Curricula Content of Pharmacovigilance and Rational Pharmacotherapy- Related Subjects Sufficient for Future Physicians?. Türkiye Klinikleri Tıp Etiği-Hukuku Tarihi Dergisi. 2019; 27(3): 186 - 195. 10.5336/mdethic.2019-66097
IEEE GÜNER M,EKMEKÇİ P "Is Medical Schools, Curricula Content of Pharmacovigilance and Rational Pharmacotherapy- Related Subjects Sufficient for Future Physicians?." Türkiye Klinikleri Tıp Etiği-Hukuku Tarihi Dergisi, 27, ss.186 - 195, 2019. 10.5336/mdethic.2019-66097
ISNAD GÜNER, Müberra Devrim - EKMEKÇİ, Perihan Elif. "Is Medical Schools, Curricula Content of Pharmacovigilance and Rational Pharmacotherapy- Related Subjects Sufficient for Future Physicians?". Türkiye Klinikleri Tıp Etiği-Hukuku Tarihi Dergisi 27/3 (2019), 186-195. https://doi.org/10.5336/mdethic.2019-66097